A detailed history of Jane Street Group, LLC transactions in Opko Health, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 2,806,921 shares of OPK stock, worth $4.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,806,921
Previous 530,540 429.07%
Holding current value
$4.72 Million
Previous $790,000 422.28%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.4 - $1.64 $3.19 Million - $3.73 Million
2,276,381 Added 429.07%
2,806,921 $4.13 Million
Q3 2024

Nov 14, 2024

SELL
$1.21 - $1.68 $371,517 - $515,825
-307,039 Reduced 36.66%
530,540 $790,000
Q2 2024

Aug 14, 2024

SELL
$1.21 - $1.42 $589,564 - $691,885
-487,243 Reduced 36.78%
837,579 $1.05 Million
Q1 2024

May 15, 2024

BUY
$0.87 - $1.57 $841,009 - $1.52 Million
966,678 Added 269.91%
1,324,822 $1.59 Million
Q4 2023

Feb 14, 2024

BUY
$1.23 - $1.63 $266,133 - $352,681
216,369 Added 152.61%
358,144 $540,000
Q3 2023

Nov 14, 2023

SELL
$1.5 - $2.17 $590,811 - $854,706
-393,874 Reduced 73.53%
141,775 $226,000
Q2 2023

Aug 14, 2023

BUY
$1.37 - $2.17 $556,715 - $881,805
406,362 Added 314.31%
535,649 $1.16 Million
Q1 2023

May 15, 2023

SELL
$1.06 - $1.61 $541,153 - $821,940
-510,522 Reduced 79.79%
129,287 $188,000
Q4 2022

Feb 14, 2023

SELL
$1.05 - $2.01 $469,270 - $898,317
-446,924 Reduced 41.13%
639,809 $799,000
Q3 2022

Nov 14, 2022

BUY
$1.81 - $2.81 $885,327 - $1.37 Million
489,131 Added 81.85%
1,086,733 $2.05 Million
Q3 2022

Nov 14, 2022

BUY
$1.81 - $2.81 $885,327 - $1.37 Million
489,131 Added 81.85%
1,086,733 $2.05 Million
Q2 2022

Aug 16, 2022

BUY
$2.33 - $3.61 $135,766 - $210,351
58,269 Added 10.8%
597,602 $1.51 Million
Q1 2022

May 17, 2022

SELL
$2.87 - $4.93 $2.3 Million - $3.96 Million
-802,895 Reduced 59.82%
539,333 $1.86 Million
Q4 2021

Feb 15, 2022

BUY
$3.52 - $5.15 $3.04 Million - $4.45 Million
863,575 Added 180.42%
1,342,228 $6.46 Million
Q3 2021

Nov 16, 2021

SELL
$3.44 - $4.24 $218,123 - $268,849
-63,408 Reduced 11.7%
478,653 $1.75 Million
Q2 2021

Aug 16, 2021

SELL
$3.33 - $4.55 $554,461 - $757,597
-166,505 Reduced 23.5%
542,061 $2.2 Million
Q1 2021

May 18, 2021

BUY
$4.19 - $5.99 $1.83 Million - $2.62 Million
437,386 Added 161.29%
708,566 $3.04 Million
Q4 2020

Feb 17, 2021

SELL
$3.27 - $4.87 $1.32 Million - $1.97 Million
-404,261 Reduced 59.85%
271,180 $1.07 Million
Q3 2020

Nov 17, 2020

SELL
$2.99 - $5.96 $1.7 Million - $3.38 Million
-567,602 Reduced 45.66%
675,441 $2.49 Million
Q2 2020

Aug 17, 2020

BUY
$1.15 - $3.41 $609,640 - $1.81 Million
530,122 Added 74.36%
1,243,043 $4.24 Million
Q1 2020

May 15, 2020

BUY
$1.34 - $2.32 $292,937 - $507,175
218,610 Added 44.23%
712,921 $954,000
Q4 2019

Feb 14, 2020

BUY
$1.42 - $2.17 $612,894 - $936,606
431,616 Added 688.44%
494,311 $726,000
Q3 2019

Nov 14, 2019

SELL
$1.75 - $2.47 $344,792 - $486,649
-197,024 Reduced 75.86%
62,695 $131,000
Q2 2019

Aug 15, 2019

SELL
$1.79 - $2.61 $251,605 - $366,866
-140,562 Reduced 35.12%
259,719 $633,000
Q1 2019

May 16, 2019

SELL
$2.42 - $3.83 $317,583 - $502,622
-131,233 Reduced 24.69%
400,281 $1.05 Million
Q4 2018

Feb 15, 2019

BUY
$2.46 - $3.87 $1.11 Million - $1.75 Million
451,772 Added 566.54%
531,514 $1.6 Million
Q3 2018

Nov 14, 2018

SELL
$3.29 - $6.29 $228,957 - $437,733
-69,592 Reduced 46.6%
79,742 $276,000
Q2 2018

Aug 15, 2018

SELL
$2.99 - $4.99 $675,695 - $1.13 Million
-225,985 Reduced 60.21%
149,334 $702,000
Q1 2018

May 15, 2018

BUY
$3.11 - $5.12 $58,284 - $95,953
18,741 Added 5.26%
375,319 $1.19 Million
Q4 2017

Feb 15, 2018

BUY
$4.61 - $7.04 $431,343 - $658,711
93,567 Added 35.58%
356,578 $1.75 Million
Q3 2017

Nov 14, 2017

BUY
$5.88 - $7.11 $1.55 Million - $1.87 Million
263,011
263,011 $1.81 Million

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.3B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.